Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 5

Sponsor Class

OTHER 16INDUSTRY 5OTHER_GOV 1FED 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

pimodivir 1Rosuvastatin Calcium 1Cyclosporine 1Adalimumab 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Healthy × Clear all
NCT03628638 2021-02-15

2016-11

Exact Sciences Corporation

Completed
1,718 enrolled

Healthy

NCT03768609 2019-04-29

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Janssen-Cilag International NV

Phase 1 Completed
18 enrolled

Healthy

NCT02912247 2019-03-07

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Completed
183 enrolled

Healthy

NCT03242239 2017-08-21

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and HerceptinĀ® in Healthy Subjects

Alteogen, Inc.

Phase 1 Completed
105 enrolled

Healthy

NCT02300363 2015-07-09

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

Lexicon Pharmaceuticals

Phase 1 Completed
24 enrolled

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚔